Brielle Benyon

For many patients with polycythemia vera, hydroxyurea is a beneficial first-line treatment. But that’s not the case for everyone. One expert discusses which drugs should be used next.

When Paul Isenberg’s wife, Nicole, was diagnosed with stage 4 Hodgkin lymphoma shortly after the birth of their child, Gabrielle, the couple realized two things: how blessed they were and that some people going through cancer have nobody to turn to.

Patients with head and neck cancer appeared to be receptive to lung cancer screening, according to recent research performed at the University of Iowa Hospitals and Clinics.

As marijuana use continues to increase across the US – and become legalized in more states – understanding the potential negative health effects is paramount.

With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space.

The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.

Lynn Schuchter, M.D., discussed immunotherapy and BRAF/MEK inhibition at the Melanoma Action Coalition’s Fall Conference.

Brain cancer survivors are living longer, highlighting the importance of survivorship care for this population.

New drug regimens are not only personalizing the treatment of patients with mantle cell lymphoma, but they’re also improving outcomes, too, explained Chaitra S. Ujjani, M.D.

The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee voted 16-0 in support of the agency granting approval to CT-P10, a biosimilar of Rituxan (rituximab), which is a drug used to treat non-Hodgkin lymphoma.

Can providers decrease opioid prescriptions after surgery, while still managing care adequately?

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

Immunotherapy has been a buzzworthy topic in the field of bladder cancer over the last couple of years. However, according to a Food and Drug Administration (FDA) safety warning, patients with metastatic disease may need to have their treatment altered.

For many cancer survivors, the thought of returning to their cancer clinic after treatment ends may be off-putting, as it could bring up difficult memories. But Arleen Weitz could not wait to get back into the infusion center at the Sidney Kimmel Cancer Center (SKCC), Jefferson Health to do some good.

Patients with cancer are 10 times less likely to have an opioid-associated death, according to recent research conducted at Duke University.

Diagnosing and treating the disease before it turns into AML is a key area of study, said Srdan Verstovsek, M.D., Ph.D., medical oncologist and professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.

Micah Bernstein is only 7 years old and has already fought cancer three times. Now, she hopes to be an inspiration to other children.

Although immunotherapy’s use in ovarian cancer lags other cancer types, Matthew Powell, M.D., believes there is still promise for checkpoint blockades in this field, likely in combination with other agents.

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.

While a pediatric cancer diagnosis can obviously impact the child experiencing the disease, psychosocial effects can differentiate how each parent is affected, too.

With new therapies that can target specific genetic mutations in patients with lung cancer, testing the tumor’s makeup is becoming increasingly important, according to Joshua Bauml, M.D.

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

Prostate cancer is one of the most common cancers in males, with about one man in nine to be diagnosed during his lifetime, according to the American Cancer Society.

An expert discusses tips on how patients with cancer can manage their "scanxiety."

The Food and Drug Administration (FDA) approved the use of Lumoxiti (moxetumomab pasudotox-tdfk) for patients with relapsed or refractory hairy cell leukemia (HCL) who previously had at least two prior systemic therapies, including treatment with a purine nucleoside analog.

“I’m just a single person. I don’t have money. I don’t have political influence. What I do have is my running shoes,” she said during the interview.

Previously, there were concerns that older patients would not be able to handle the toxicities of the procedure, or that their stem cells, which are older, would not work as well. But that proved to not be the case.

After success in the non-small cell lung cancer space, immunotherapy is finally making waves in the treatment of small cell lung cancer.

This infographic explains some of the basics on mantle cell lymphoma, a type of non-Hodgkin lymphoma.

While there is currently no definitive way to predict who will respond and who will not, researchers at Brighton and Sussex Medical School in the United Kingdom are working on a blood test that could identify about half of those who may not.